Jordan A. Levinson, Vishnudas Sarda, and S. Bryn Austin are with the Division of Adolescent and Young Adult Medicine, Boston Children's Hospital, Boston, MA. Kendrin Sonneville is with the Department of Nutritional Sciences, School of Public Health, University of Michigan, Ann Arbor. Jerel P. Calzo is with the Division of Health Promotion and Behavioral Science, School of Public Health, San Diego State University, San Diego, CA. Suman Ambwani is with the Department of Psychology, Dickinson College, Carlisle, PA.
Am J Public Health. 2020 Jan;110(1):109-111. doi: 10.2105/AJPH.2019.305390. Epub 2019 Nov 21.
To investigate the prospective association of diet pill and laxative use for weight control with subsequent first eating disorder diagnosis in young women. We used longitudinal data from 10 058 US women spanning 2001 through 2016. We used multivariable logistic regression models, adjusting for age, race/ethnicity, and overweight status to estimate the association between weight-control behaviors and subsequent eating disorder diagnosis. Among those who had not previously received an eating disorder diagnosis, women who reported diet pill (adjusted odds ratio [AOR] = 5.6; 95% confidence interval [CI] = 3.0, 10.5) or laxative (AOR = 6.0; 95% CI = 4.2, 8.7) use for weight control had higher odds of receiving a subsequent first eating disorder diagnosis within 1 to 3 years than those who did not report using these products. Use of diet pills or laxatives for weight loss can be dangerous and may be a warning sign that warrants counseling and evaluation for the presence of or risk of developing an eating disorder. Policymakers and public health professionals should develop and evaluate policy initiatives to reduce or prohibit access to diet pills and laxatives abused for weight control.
为了研究减肥药和泻药用于控制体重与年轻女性随后首次饮食失调诊断之间的前瞻性关联。我们使用了 2001 年至 2016 年期间跨度为 10058 名美国女性的纵向数据。我们使用多变量逻辑回归模型,根据年龄、种族/民族和超重状况进行调整,以估计控制体重的行为与随后的饮食失调诊断之间的关联。在那些以前没有接受过饮食失调诊断的女性中,报告使用减肥药(调整后的优势比 [AOR] = 5.6;95%置信区间 [CI] = 3.0,10.5)或泻药(AOR = 6.0;95%CI = 4.2,8.7)用于控制体重的女性,在 1 至 3 年内接受后续首次饮食失调诊断的可能性高于未报告使用这些产品的女性。减肥药或泻药用于减肥可能是危险的,可能是一个警告信号,需要进行咨询和评估是否存在或有发展饮食失调的风险。政策制定者和公共卫生专业人员应制定和评估政策举措,以减少或禁止滥用减肥药和泻药来控制体重。